1. Home
  2. IMXI vs KROS Comparison

IMXI vs KROS Comparison

Compare IMXI & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$15.36

Market Cap

456.2M

Sector

Technology

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$20.04

Market Cap

655.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
KROS
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.2M
655.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
IMXI
KROS
Price
$15.36
$20.04
Analyst Decision
Buy
Buy
Analyst Count
3
12
Target Price
$16.67
$22.20
AVG Volume (30 Days)
241.4K
1.0M
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.29
1.57
Revenue
$625,123,000.00
$246,718,000.00
Revenue This Year
N/A
$6,876.34
Revenue Next Year
$0.95
N/A
P/E Ratio
$11.91
$12.87
Revenue Growth
N/A
37798.31
52 Week Low
$8.58
$9.12
52 Week High
$21.41
$22.55

Technical Indicators

Market Signals
Indicator
IMXI
KROS
Relative Strength Index (RSI) 60.67 57.46
Support Level $15.35 $20.73
Resistance Level $15.51 $21.75
Average True Range (ATR) 0.06 1.06
MACD -0.02 -0.12
Stochastic Oscillator 39.62 58.36

Price Performance

Historical Comparison
IMXI
KROS

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: